Simulations Plus, Inc.

Simulations Plus, Inc.SLPEarnings & Financial Report

Nasdaq · Information Technology · Services-Computer Integrated Systems Design

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

Revenue

$22.4M

Gross Profit

$13.1M

Operating Profit

$2.7M

Net Profit

$3.1M

Gross Margin

58.5%

Operating Margin

12.1%

Net Margin

13.7%

YoY Growth

22.5%

EPS

$0.15

Simulations Plus, Inc. Q2 FY2025 Financial Summary

Simulations Plus, Inc. reported revenue of $22.4M (up 22.5% YoY) for Q2 FY2025, with a net profit of $3.1M (down 23.7% YoY) (13.7% margin). Cost of goods sold was $9.3M, operating expenses totaled $10.4M.

Key Financial Metrics

Total Revenue$22.4M
Net Profit$3.1M
Gross Margin58.5%
Operating Margin12.1%
Report PeriodQ2 FY2025

Revenue Breakdown

Simulations Plus, Inc. Q2 FY2025 revenue of $22.4M breaks down across 2 segments, led by License And Maintenance at $13.5M (60.1% of total).

SegmentRevenue% of Total
License And Maintenance$13.5M60.1%
Services Segment$8.9M39.9%

Simulations Plus, Inc. Revenue by Segment — Quarterly Trend

Simulations Plus, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as License And Maintenance and Services Segment) has evolved quarter over quarter.

SegmentQ1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
License And Maintenance$9.0M$12.6M$13.5M
Services Segment$9.5M$8.4M$7.7M$8.9M

Simulations Plus, Inc. Annual Revenue by Year

Simulations Plus, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $79.2M).

YearAnnual Revenue
2025$79.2M
2024$70.0M
2023$59.6M
2022$53.9M

Simulations Plus, Inc. Quarterly Revenue & Net Profit History

Simulations Plus, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q1 FY2026$18.4M-2.7%$676.0K3.7%
Q4 FY2025$17.5M-6.5%$-681.0K-3.9%
Q3 FY2025$20.4M+9.8%$-67.3M-330.6%
Q2 FY2025$22.4M+22.5%$3.1M13.7%
Q1 FY2025$18.9M+30.5%$206.0K1.1%
Q4 FY2024$18.7M+19.4%$843.0K4.5%
Q3 FY2024$18.5M+14.2%$3.1M16.9%
Q2 FY2024$18.3M+16.2%$4.0M22.0%

Income Statement

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Revenue$18.3M$18.5M$18.7M$18.9M$22.4M$20.4M$17.5M$18.4M
YoY Growth16.2%14.2%19.4%30.5%22.5%9.8%-6.5%-2.7%

Balance Sheet

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Assets$194.0M$192.7M$196.6M$196.9M$201.4M$134.4M$131.9M$137.8M
Liabilities$16.9M$11.8M$14.2M$12.2M$11.9M$10.6M$7.1M$10.7M
Equity$177.0M$180.9M$182.4M$184.7M$189.5M$123.8M$124.8M$127.1M

Cash Flow

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Operating CF$5.8M$5.7M$1.7M$-1.3M$5.7M$8.1M$5.6M$4.2M